Trial intelligence / Profile preview

PPOS vs GnRH-antagonist in PCOS

NCT05939284Completed

Sponsor
Zagazig University
Start
Jun 2021
Primary completion
Sep 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dydrogesterone in infertility (2 arms), sponsored by Zagazig University. Primary endpoint: Success rate of PPOS in relation to Premature LH surge suppression at 12 months. Started Jun 2021; status: completed.

02

Drugs

dydrogesterone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT05939284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05939284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call